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Monday, February 4, 2013 239aPiscidins, which are antimicrobial peptides (AMPs) produced in the mast cells
of hybrid striped bass, are found in immune-related organs as well as non-
immune tissues, including neuronal cell bodies. While they are unstructured
in water, they form amphipathic, cationic and alpha-helical structure in the
presence of lipid bilayers at physiological pH. The biologically most active pis-
cidin, piscidin 1 (P1), has broad spectrum antimicrobial activity against various
bacteria, fungi, and viruses. Recently, it was found to be selective against
HT1080 and HeLa cells as compared to healthy cells. This research investigates
the factors that imparts P1 this selectivity against cancer cells. We have been
particularly interested in special chemical properties of cancer cells, such as
their low extracellular pH, presence of phosphatidylserine (PS) in the outer
membrane leaflet, and elevated cholesterol level. We hypothesize that the pos-
itive charges on the histidine residues of P1 at the low extracellular pH of can-
cer cells allow P1 to align parallel to the surface and disrupt the membrane via
the carpet-like mechanism of action.
Lipid membranes have been made using 2:2:1 phosphatidylcholine/phoshati-
dylserine/cholesterol to mimic tumor cells. Circular dichroism experiments
were performed using large unilamellar vesicles to investigate the effect of
pH, cholesterol, and lipid charge on the peptide’s helical content and therefore
affinity for lipid bilayers. Using 2H and 15N solid-state NMR, we have inves-
tigated the fluidity of the lipid bilayers and bilayer orientation of P1, respec-
tively. These results are contrasted with those obtained on healthy
mammalian cell mimics. The principles learned from these studies could
help design peptides with enhanced activity against cancer cells.
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A hallmark feature of Alzheimer’s disease is formation of extracellular plaques
of the amyloid b (Ab) peptide. There is evidence that the Ab peptide inserts into
the membranes of surrounding neuronal cells, causing membrane permeabiliza-
tion or rupture. The level of cholesterol in membranes has been shown to affect
the extent and toxicity of Ab plaques, as well as the mode of membrane inser-
tion of Ab and its structure. Here we analyze the effect of cholesterol on the
secondary structure of the 40-residue Ab peptide in artificial lipid bilayers.
Multilayers composed of 0.3 mol fraction of 1-palmitoyl-2-oleoyl-phosphati-
dylglycerol, (0.7 - Xchol) mol fraction of 1-palmitoyl-2-oleoyl-phosphatidyl-
choline, and Xchol mol fraction of cholesterol were deposited on
a germanium plate, with Xchol = 0, 0.05, 0.1, 0.2 and 0.4, containing Ab at
a 1:15 peptide/lipid molar ratio. Fourier transform infrared spectra were col-
lected on lipid-peptide samples under three conditions, i) dry multilayers, ii)
humidified with D2O vapors, and iii) in the presence of a bulk D2O-based
buffer. In all cases, the amide I bands of the peptide indicated comparable frac-
tions of a-helical and b-sheet structures. Increase of Xchol from 0 to 0.2 resulted
in a significant decrease in the b-sheet structure and a slight increase in a-helix
content. Further increase in Xchol to 0.4 reversed the b-sheet content and in-
creased the a-helical structure; the latter effect was much stronger in hydrated
samples. Considering that cholesterol at Xchol> 0.2 causes a fluid-disordered to
fluid-ordered transition in membranes, the observed structural effects may re-
flect either conformational changes in membrane-bound Ab peptide or
a squeezing-out effect. These possibilities, as well as the effect of cholesterol
on membrane permeabilization will elucidate the role of cholesterol in Ab
structure and function.
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The Alzheimer’s Ab peptides are shown to increase the cytosolic calcium con-
centrations of cells in culture. Such an alteration may cause a variety of second-
ary effects, leading to cell degeneration and reduced cell culture growth.
Cytosolic calcium concentration can be increased by the formation of cation-
selective ion channels by the Ab peptides. This property is well documented
and has been extensively studied both in artificial membrane systems as well
as in living cells. Here we show that L-type calcium channel antagonists, com-
monly used in the treatment of hypertension and ischemic heart disease, inten-
sify the capacity of Ab peptides to increase cytosolic calcium concentrations
and consequently enhance the cytotoxicity of the Ab peptides. Calcium imag-
ing experiments were conducted with the fluorescent indicator Fura-2 to mea-
sure at different periods of times the levels of cytosolic calcium duringexposure to Ab peptides and to the L-type calcium channel antagonists. Two
different 1,4-dihydropyridines (nifedipine, and nitrendipine), and Diltiazem,
a structurally unrelated Ca2þ-channel antagonist belonging to the phenylalkyl-
amine class were used and found to exert significant excitatory effects on the
toxicity of Ab. The reduced toxicity observed in solutions of combinations
of Ab40 and Ab42 is also reversed by L-type calcium channel antagonists.
The toxicity of Ab peptides was weighed by quantifying the growth of cultures
of PC12 cells using the colorimetric assay XTT and by measuring the release of
LDH to the media. The enhancement of the Ab peptides toxicity by L-type cal-
cium channel antagonists can be constrained by specific Ab ion channel
blockers suggesting the mediation of the ion channel property of Ab peptides.
The relevance of our finding derives from the widespread clinical use of L-type
calcium channel antagonists in the treatment of hypertension and angina
pectoris.
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The Alzheimer’s Ab peptides interaction with the plasma membrane has been
shown to result in a chronic increase in the cytosolic calcium concentrations of
cells in culture. Such alteration may cause a variety of secondary effects which
may lead to cell degeneration and reduced cell culture growth. We have pro-
posed that the alteration in the cytosolic calcium concentrations induced by
Ab is initiated by early formation of Ab ion channels in the plasma membrane.
To study the Ab-induced cytosolic calcium change dynamics we monitored the
level of cytosolic calcium from hundreds of individual cells in culture exposed
to Ab for prolonged period of time. Because of the continuous cytotoxic effect
of Ab on cells, the number of viable cells in the cultures varied with time of
exposure. Histograms based on the individual intracellular calcium levels
showed that while most cells in the culture remain unaffected, a defined sub-
population of cells show increasingly higher than normal cytosolic calcium
levels. After days of continuous exposure to Ab cells more sensitive to Ab
died, and consequently the averaged cytosolic calcium for remaining cells in
the whole culture approached control values. Ab ion channel blockers pre-
vented the induced cytosolic calcium changes and preserved cell viability, con-
firming the participation of Ab ion channels. Confocal microscopic analysis
using fluorescent annexin V on cells loaded with fura 2 showed that those cells
that remained after prolonged exposure to Ab did not display the proposed ex-
tracellular Ab receptor phosphatidyl serine. Further addition of Ab to this
sorted cell subpopulation did not induce cytosolic calcium changes and cells
continued to grow and divide. Application of this procedure allows for sorting
out Ab resistant subpopulation of cells.
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Alzheimer’s Amyloid-b peptide (Ab) is a 39-42 amino acid fragment of the
amyloid precursor protein. Accumulation of the neurotoxic Ab in the brains
of Alzheimer’s patients forms detrimental plaques. Another mechanism of neu-
ronal damage is membrane destabilization by insertion of the peptide into brain
cell membranes and disruption of ionic homeostasis. The molecular mechanism
of membrane permeabilization by Ab remains largely uncharacterized. Exper-
iments with live cells and lipid membranes have identified ion channels formed
by Ab. The channel formed by an 11 amino acid residue fragment, Ab25-35,
has been modeled by Molecular Dynamics simulations as an 8-stranded b-bar-
rel, but this structure has not been supported by direct experimental data. The
objective of this work was to study the mechanism of membrane permeabiliza-
tion by Ab using biophysical techniques. Unilamellar lipid vesicles were pre-
pared in a buffer containing 30 mM CaCl2, followed by removal of calcium
from the external medium via a desalting column and addition of 0.1 mM
Quin-2, a fluorescent calcium indicator. Before peptide addition, the vesicle
sample showed little fluorescence because of spatial sequestration of calcium
and Quin-2. Addition of submicromolar concentration of the Ab25-35 peptide
resulted in gradual increase in Quin-2 fluorescence, indicating formation of
Ca2þ-permeable pores in vesicle membranes. Addition of higher concentra-
tions of the peptide resulted in instantaneous increase in fluorescence, compa-
rable to the effect of detergents like Triton X-100, indicating rupture of vesicle
membranes. Thus, the data suggest membrane pore formation at low peptide
concentrations and membrane disruption at higher concentrations. These data
are consistent with a mechanism of detergent-like action of the Ab peptide;
